TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling.
Pagano E, Romano B, Cicia D, Iannotti FA, Venneri T, Lucariello G, Nanì MF, Cattaneo F, De Cicco P, D'Armiento M, De Luca M, Lionetti R, Lama S, Stiuso P, Zoppoli P, Falco G, Marchianò S, Fiorucci S, Capasso R, Di Marzo V, Borrelli F, Izzo AA.
Pagano E, et al. Among authors: falco g.
Br J Pharmacol. 2023 Jan;180(2):235-251. doi: 10.1111/bph.15960. Epub 2022 Oct 17.
Br J Pharmacol. 2023.
PMID: 36168728
Free PMC article.